Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
Nature Medicine2012Vol. 18(8), pp. 1254–1261
Citations Over TimeTop 1% of 2012 papers
Steffen Walter, Toni Weinschenk, Arnulf Stenzl, Romuald Zdrojowy, A Płużańska, Cezary Szczylik, Michael Staehler, Wolfram Brugger, Pierre-Yves Dietrich, Regina Mendrzyk, Norbert Hilf, Oliver Schoor, Jens Fritsche, Andrea Mahr, Dominik Maurer, Verona Vass, Claudia Trautwein, Peter Lewandrowski, Christian Flohr, Heike Pohla, Janusz J Stańczak, Vincenzo Bronte, Susanna Mandruzzato, Tilo Biedermann, Graham Pawelec, Evelyna Derhovanessian, Hisakazu Yamagishi, Tsuneharu Miki, Fumiya Hongo, Natsuki Takaha, Kosei Hirakawa, Hiroaki Tanaka, Stefan Stevanović, Jürgen Frisch, Andrea Mayer-Mokler, Alexandra Kirner, Hans-Georg Rammensee, Carsten Reinhardt, Harpreet Singh‐Jasuja
Related Papers
- → USE OF CYCLOPHOSPHAMIDE AND ENHANCING SERUM TO SUPPRESS RENAL ALLOGRAFT REJECTION IN THE RAT(1979)13 cited
- → Pseudomonas aeruginosa Infection in Mice After Treatment With Cyclophosphamide(1975)8 cited
- → Experimental Study of Ultralow-Dose Antibodies to Cyclophosphamide on Cyclophosphamide Myelotoxicity(2009)1 cited
- → Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice(2015)1 cited
- → The role of Foxp3 in Treg homeostatic proliferation: Necessary for nTregs, but insufficient for iTregs. (LYM3P.734)(2014)